Report Categories
View AllRecent Articles
View All
Celldex CLDX Operational Review Q4 2025 Earnings Underperform
CVRx CVRX Stock Fundamentals Smart Money Exits 20260415
FATN FatPipe Inc posts 88 percent Q1 2026 year over year revenue decline shares rise modestly
KraneShares CSI China Internet ETF KWEB Contrarian Opportunity Emerges as Chinas Economic Recovery Gains Traction
Is Rein Therapeutics RNTX stock gaining strength Momentum Building 20260420
Is Theriva Biologics TOVX stock breaking out today Investors Pile In 20260420
Why Sonoco SON deserves a deeper look right now 114 20260511
What ORIX IXs 097 Decline Means for Investors 20260515
US USEG Climbs 230 Resistance at 101 in Focus 20260515
Malaysias Q1 GDP Growth Slows to 54 as Cost Pressures Mount
Koninklijke PHG Q1 2026 Earnings EPS 023 Beats Estimates
Inflation Accelerates as Conflict in Iran Disrupts Global Markets
Inflation Rate Projected to Reach 6 in Q2 as Pressures Persist
NATO to Spend Hundreds of Billions on Defense as Trump Pledges 5000 Troops to Poland Rutte
Walmart Shares Plunge in Largest Daily Decline in Four Years
Michael Burry Warns SECs CryptoStyle Trading Plan Could Spell Trouble for Investors
US Productivity Growth Decelerates in Q4 as Labor Costs Rise
SAP Unveils Vision for Next Era of Business AI
Jamie Dimon Signals Potential Challenges for JPMorgan Bankers Amid Economic Uncertainty
PRTS Q1 2026 Earnings EPS Surprises with 4885 Beat Stock Falls 392
HRI Q1 2026 Earnings Strong EPS Beat Surprises Market
LMT Q1 2026 Earnings Earnings Miss Stock Rises Amid Defense Sector Optimism
SITM Q1 2026 Earnings EPS Soars Past Consensus by 22 Stock Declines Marginally
TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed
CIMP Q1 2026 Earnings EPS Beats Estimates as Mortgage REIT Maintains Stable Performance
Neuphoria Therapeutics NEUP Soars 7 Key Levels to Watch After Bullish Breakout
Pentair PNR Slips 173 as Stock Tests Key Support Levels
InMode INMD Pushes Higher Testing Resistance After a 16 Gain
Nasus Pharma NSRX Gains 389 as Biotech Investors Eye Key Resistance
Ziff Davis ZD Hovers Near Support as Consolidation Persists